comparemela.com
  1. Home
  2. Live Updates
  3. Primon Lara - Breaking News

Latest Breaking News On - Primon lara - Page 1 : comparemela.com

Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer

For patients with clear cell renal cell carcinoma (RCC) at very high risk for recurrence, adjuvant everolimus is associated with significantly improved recurrence-free survival.

United statesUniversity of california davisPrimon laraEuropean society for medical oncologyUniversity of california davis comprehensive cancer centerHealthday newsEuropean societyMedical oncologyCalifornia davis comprehensive cancer center

Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer

Findings seen in clear cell renal cell carcinoma patients at very high disease risk after nephrectomy from EVEREST trial

University of california davisUnited statesPrimon laraEuropean society for medical oncologyUniversity of california davis comprehensive cancer centerHealthday newsEuropean societyMedical oncologyCalifornia davis comprehensive cancer center

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.